Section Arrow
Quote
XLO.NASDAQ
- Xilio Therapeutics Inc.
Quotes are at least 15-min delayed:2026/06/10 08:05 EDT
Pre Market
Last
 7.61
-0.29 (-3.67%)
Bid
7.5
Ask
9
High 7.64 
Low 7.61 
Volume 2 
Regular Hours (Closed)
Last
 7.9
+0.22 (+2.86%)
Day High 
7.93 
Prev. Close
7.68 
1-M High
8.9999 
Volume 
37.42K 
Bid
7.5
Ask
9
Day Low
7.57 
Open
7.62 
1-M Low
7.53 
Market Cap 
50.50M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.2 
20-SMA 8.2 
50-SMA 8.26 
52-W High 12.7386 
52-W Low 6.4652 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.28/-4.23
Enterprise Value
56.11M
Balance Sheet
Book Value Per Share
11.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
43.77M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.0289-0.021-42.08%-- 
Pre Market 0.0207 -0.0082 -28.37%
NUVLNuvalent123.25+34.76+39.28%-- 
Pre Market 123.25 0 0.00%
RXRXRecursion Pharmaceuticals3.22-0.1-3.01%-- 
Pre Market 3.115 -0.105 -3.26%
GERNGeron Corp1.12-0.01-0.88%-- 
Pre Market 1.12 0 0.00%
GOSSGossamer Bio0.16-0.0056-3.38%-- 
Pre Market 0.161 +0.001 +0.63%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Itsintegrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.